Elevance Health Plunges on Guidance Cut; PepsiCo Beats Estimates; Eliquis Discount Announced

By / / Breaking News

  • Elevance Health (ELV) saw its shares impacted after reporting Q2 2025 adjusted earnings per share (EPS) of $8.84, falling short of the $8.94 estimate. While operating revenue of $49.42 billion surpassed the $48.14 billion estimate, the company significantly revised its full-year adjusted EPS outlook to approximately $30, down from its previous range of $34.15-$34.85. Following this, Bernstein cut its price target for Elevance Health to $487 from $585.

  • PepsiCo (PEP) delivered a strong Q2 2025 performance, with core EPS reaching $2.12, exceeding the $2.03 estimate, and net revenue climbing to $22.73 billion against an estimated $22.28 billion. The company also reported Q2 organic revenue growth of 2.1%, surpassing the 1.9% estimate. Despite operating profit coming in at $1.79 billion (below the $3.89 billion estimate), PepsiCo affirmed its 2025 financial guidance, including a full-year core constant FX EPS of about even and a low-single-digit organic revenue increase. The company now anticipates a foreign exchange translation headwind of about 1.5 percentage points to impact full-year reported net revenue and core EPS growth.

  • In the pharmaceutical sector, Bristol-Myers Squibb (BMY) and Pfizer (PFE) are reportedly planning to offer their widely used blood thinner, Eliquis, at a discount. This development was exclusively reported by the Wall Street Journal.

  • Concerns are mounting within the Russian banking sector, as institutions have reportedly discussed seeking government bailouts within the next year. This comes amidst privately expressed worries over worsening bad loans, with documents indicating that at least three Russian banks have weighed the risk of needing a bailout in the coming year.

  • In international trade news, Thailand is set to offer no duties on 90% of American goods. This improved offer is aimed at avoiding a potential 36% Trump tariff, signaling an effort to enhance trade relations and prevent punitive measures.

  • Meanwhile, China has adjusted its consumption tax policy specifically for luxurious and super luxury cars, a move that could impact the high-end automotive market within the country.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top